Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shirley Gough"'
Autor:
Kristi M. Schurman, M. Robyn Andersen, Barbara A. Goff, Nicole Urban, Shirley Gough, Barry S. Mahony, Charles W. Drescher, Joshua Patras, Lynn S. Mandel
Publikováno v:
Cancer. 109:221-227
Currently, screening for ovarian cancer is not recommended for the general population. Targeting women with specific symptoms for screening has been evaluated only recently, because it was believed that symptoms had limited specificity.A case-control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4da904b279951693befc2e7f4d476232
https://doi.org/10.1002/cncr.22371
https://doi.org/10.1002/cncr.22371
Publikováno v:
Clinical Cancer Research. 23:AP02-AP02
OCEDP STUDY AIMS: The purpose of this screening study program was do test whether CA–125 blood tests and annual ovarian ultrasounds help detect ovarian cancer early in women at increased risk. RISK ELIGIBILITY CRITERIA:– 2 first or second degree
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b73af7b84e8598b869fbec24c3e0276
https://doi.org/10.1158/1557-3265.ovcasymp16-ap02
https://doi.org/10.1158/1557-3265.ovcasymp16-ap02
Autor:
Jason D. Thorpe, Charles W. Drescher, Ingegerd Hellström, Nicole Urban, Michèl Schummer, Shirley Gough, Karl Erik Hellström, Robin M. Forrest
Publikováno v:
Gynecologic oncology. 125(1)
Objective Evaluate and compare the effectiveness of CA125, HE4, Mesothelin and MMP7 marker levels to monitor ovarian cancer patients after surgery and chemotherapy. Evaluate the lead time of a rise of marker levels before recurrence. Methods The stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b490267045332d0598e962094475adf
https://pubmed.ncbi.nlm.nih.gov/22155417
https://pubmed.ncbi.nlm.nih.gov/22155417
Autor:
M. Robyn Andersen, Charles W. Drescher, Nicole Urban, Lynn S. Mandel, Barbara A. Goff, Kristi M. Schurman, Barry S. Mahony, Joshua Patras, Shirley Gough
Publikováno v:
Obstetrical & Gynecological Survey. 62:379-380
Ovarian cancer is the second most common gynecologic malignancy in the US and-because more than 70% of women affected are diagnosed with advanced-stage disease-the deadliest. Contrary to what might be expected, screening has not lessened mortality ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bc64bf0c31a7346204bdf735305c980
https://doi.org/10.1097/01.ogx.0000265905.84107.45
https://doi.org/10.1097/01.ogx.0000265905.84107.45
Autor:
Barbara A. Goff, Lynn S. Mandel, Charles W. Drescher, Nicole Urban, Shirley Gough, Kristi M. Schurman, Joshua Patras, Barry S. Mahony, M. Robyn Andersen
Publikováno v:
Cancer (0008543X); Jan2007, Vol. 109 Issue 2, p221-227, 7p